Lonza

Activities: Manufacturing Ingredients

Now a Lonza Company

Trending Articles

  1. Germfree mobile cleanroom finishes pilot programme for hospital lidocaine production Modular cleanroom expert Germfree and pharma expert ODP are now working to expand a pilot programme after a successful six months of producing medications at North Mississippi...
  2. Syntegon launches new "Settle Plate Changer" for automated viable monitoring Syntegon has patented its new Settle Plate Changer (SPC) for automated viable monitoring in the aseptic filling process
  3. Swedish Nefab opens 25,000 sqft semiconductor packaging facility in Penang suburb The new facility in Batu Kawan, Malaysia, contains a cleanroom that will become operational in 2025
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Integrity testing of HEPA filters: A practical approach Filtering the air in aseptic process areas is critical to maintaining the cleanliness of the production environment. Jesus Casas provides tips to ensure HEPA filters are fit...
  5. Angstrom Technology Angstrom Technology are the UK & Europe’s leading full-solution provider, for the supply and operation of cleanrooms and critical environments.

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Regulatory

UPDATE: US Pharmacopeia makes comments public on endotoxin testing overhaul

The USP has published the comments the organisation received in response to the addition of non-animal derived endotoxin testing methods, as well as an FAQ page on the issue
Analysis

Lonza makes decision on new CEO

Wolfgang Wienand, currently CEO of Swiss CDMO Siegfried, will become Chief Executive Officer of Lonza in the summer of 2024
Cleaning

Lonza expands PyroCell pyrogen testing portfolio with two new rapid systems

Lonza has launched PyroCell MAT Rapid System and PyroCellMAT Human Serum (HS) Rapid System, two sustainable monocyte activation test (MAT) systems containing the new PeliKine Human IL-6 Rapid ELISA Kit
Analysis

Lonza to phase out traditional endotoxin testing LAL and TAL assay reader for new tech

The company has launched the Nebula Absorbance Reader that is a technologically advanced, high-performance replacement reader, which delivers results comparable to those typically found with the traditional method and will facilitate the smooth continuation of current pyrogen and endotoxin testing programmes
Pharmaceutical

Q&A: Lonza’s PyroCell Monocyte activation test

Lonza has launched the PyroCell MAT that uses human serum instead of foetal bovine serum for pharmaceutical testing, but how does it change the status quo?
Design & Build

Lonza commissions BAM for Chemelot mRNA facility renovation

Lonza has commissioned BAM to renovate the ground floor up to and including the second floor of its Brighthouse building 300 on the Brightlands Chemelot Campus
Cleaning

Q&A on Lonza’s new PyroCell Monocyte Activation Test

Speaking to Katrin Pauls from Lonza about the launch of the company's PyroCell MAT, which uses human serum instead of foetal bovine serum for pharmaceutical testing, and how it changes the status quo
Subscribe now